It's Tuesday and this is what I'm reading: Recalls happen every day and cost a lot of money, there is a way to insure against that financial loss, but few companies know about it or insure against it - Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of Valsartan and Valsartan Hydrochlorothiazide Tablets (Business Wire). 4 … Continue reading Tuesday Morning Articles of Interest
Tag: CRISPR
Monday Morning Reads
Good morning and welcome to the start of another week. Here is what I am reading as we kick off the final week in June: How CRISPR Gene Editing Is Revolutionizing Medicine And The Companies Who Invest In It Targeting cancer cells' escape vehicles to stop tumor metastasis Does your clinical trial policy include coverage … Continue reading Monday Morning Reads
Tuesday Morning Reads
Here is what I'm reading this morning: Gene editing stocks get bushwhacked as new studies highlight CRISPR/Cas9 cancer risks Pharma R&D Investments Moderating -- But Still High R&D Is Time Consuming and Expensive. Robotics, 3D Printing, & AR/VR Are Changing That. Fixing the Clinical Trial Bottleneck by Making Patients a Priority
MattCorc 